Auxilium Pharma Reports XIAFLEX Data from Multicord, Retreatment Studies at ASSH Annual Meeting
September 18, 2014 at 07:12 AM EDT
Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a specialty biopharmaceutical company, today announced the first presentation of ...